John J. Kirby

CIK: 0001556327

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VRCA

Verrica Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

VRCA
Verrica Pharmaceuticals Inc.
Aug 18, 2026
Purchase(P)
Direct
5K shares at avg. $4.93$25K
VRCA
Verrica Pharmaceuticals Inc.
Dec 23, 2025
Award(A)
Direct
10K shares-
VRCA
Verrica Pharmaceuticals Inc.
Nov 25, 2025
Purchase(P)
Direct
3.5K shares at avg. $4.24$15K
VRCA
Verrica Pharmaceuticals Inc.
Nov 6, 2024
Award(A)
Direct
54.3K shares-

		Type	Shares	Price		Ownership
Aug 18, 2026	VRCA Verrica Pharmaceuticals Inc.	Purchase(P)	5,000	$4.93	$24,650	Direct
Dec 23, 2025	VRCA Verrica Pharmaceuticals Inc.	Award(A)	10,000	-	-	Direct
Nov 25, 2025	VRCA Verrica Pharmaceuticals Inc.	Purchase(P)	3,536	$4.24	$15,001	Direct
Nov 6, 2024	VRCA Verrica Pharmaceuticals Inc.	Award(A)	54,267	-	$0	Direct

1-4 of 4 transactions

About Kirby John J.

Kirby John J. (SEC CIK 0001556327) files insider reports with the SEC as Interim CFO of Verrica Pharmaceuticals Inc. (VRCA).

Signal8 holds 5 ownership filings by Kirby John J. (1 Form 3, 4 Form 4), filed between Nov 6, 2024 and Aug 18, 2026. Those filings report 4 transactions, from Nov 6, 2024 to Aug 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kirby John J.'s filings is in WEST CHESTER, PA.

Recent filings by Kirby John J.

Aug 18, 2026: Open-market purchase of VRCA shares (Form 4, code P).
Dec 23, 2025: Grant or award of VRCA shares (Form 4, code A).
Nov 25, 2025: Open-market purchase of VRCA shares (Form 4, code P).
Nov 6, 2024: Grant or award of VRCA shares (Form 4, code A).

Other insiders filing for Verrica Pharmaceuticals Inc. (VRCA)

Zawitz David, Chief Operating Officer
Rieger Jayson, CEO and President
Rosenberg Noah L., CMO
Eichenfield Lawrence, Director
Nguyen Diem, Director
PRYGOCKI MARK A SR, Director

How to read Form 4 transaction codes